Heptares Therapeutics

About:

Heptares Therapeutics develops novel, small-molecule drugs for G-protein-coupled receptors (GPCRs).

Website: https://soseiheptares.com/

Twitter/X: soseiheptaresco

Top Investors: Teva Pharmaceuticals, Novartis Venture Fund, MVM Life Science Partners, Takeda Ventures, Clarus Ventures

Description:

Heptares Therapeutics is a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets. The Company has developed a unique, transformational and proprietary technology for making purified, stabilised and functional GPCRs (known as StaRs, Stabilised Receptors), overcoming a major limiting factor to the development of new drugs targeting this group.